Camrelizumab

• CAT Number: I044210
• CAS Number: 1798286-48-2
• Purity: ≥95%

Camrelizumab（Cat No.:I044210）is a humanized IgG4 monoclonal antibody that targets programmed death-1 (PD-1), an immune checkpoint receptor expressed on T cells. By blocking PD-1 interaction with its ligands (PD-L1 and PD-L2), camrelizumab restores T cell activation and enhances anti-tumor immune responses. It is used in the treatment of various cancers, including non-small cell lung cancer, hepatocellular carcinoma, and Hodgkin lymphoma. Camrelizumab is known for its efficacy in immune checkpoint blockade therapy, with a distinctive side effect of reactive capillary endothelial proliferation. It plays a crucial role in immuno-oncology strategies.